These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36315147)

  • 1. Association of Vaginal Progesterone Treatment With Prevention of Recurrent Preterm Birth.
    Nelson DB; Lafferty A; Venkatraman C; McDonald JG; Eckert KM; McIntire DD; Spong CY
    JAMA Netw Open; 2022 Oct; 5(10):e2237600. PubMed ID: 36315147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
    Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
    PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC; Schoen CN; Frey H; Gimovsky AC; Springel E; Backley S; Berghella V
    Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Vaginal and Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth.
    Frey HA; Finneran MM; Hade EM; Waickman C; Lynch CD; Iams JD; Landon MB
    Am J Perinatol; 2023 Nov; 40(15):1695-1703. PubMed ID: 34905780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
    Wang SW; Ma LL; Huang S; Liang L; Zhang JR
    Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does adjunctive use of progesterone in women with cerclage improve prevention of preterm birth?
    Sinkey RG; Garcia MR; Odibo AO
    J Matern Fetal Neonatal Med; 2018 Jan; 31(2):202-208. PubMed ID: 28068860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use.
    Conde-Agudelo A; Romero R
    J Perinat Med; 2023 Jan; 51(1):125-134. PubMed ID: 36475431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.
    Saccone G; Khalifeh A; Elimian A; Bahrami E; Chaman-Ara K; Bahrami MA; Berghella V
    Ultrasound Obstet Gynecol; 2017 Mar; 49(3):315-321. PubMed ID: 27546354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Early Preterm Birth Despite Vaginal Progesterone Therapy in Singletons with Short Cervix.
    Boelig RC; Naert MN; Fox NS; Hennessy S; Chervoneva I; Berghella V; Roman A
    Am J Perinatol; 2020 Nov; 37(13):1289-1295. PubMed ID: 32344443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials.
    Suhag A; Saccone G; Berghella V
    Am J Obstet Gynecol; 2015 Oct; 213(4):479-87. PubMed ID: 25797233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy of vaginal progesterone in preventing preterm birth after abdominal trachelectomy.
    Sato Y; Hidaka N; Sakai A; Kido S; Fujita Y; Okugawa K; Yahata H; Kato K
    Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():119-124. PubMed ID: 33657512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
    Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
    Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB; McIntire DD; McDonald J; Gard J; Turrichi P; Leveno KJ
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Initiation and Long-Term Use of Vaginal Progesterone may Cause Gestational Diabetes Mellitus.
    Oztekin D; Senkaya AR; Gunes ME; Keskin O; Dogdu IA
    Z Geburtshilfe Neonatol; 2022 Jun; 226(3):173-177. PubMed ID: 35181880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A Multicenter, International, Randomized Double-Blind Trial.
    Blackwell SC; Gyamfi-Bannerman C; Biggio JR; Chauhan SP; Hughes BL; Louis JM; Manuck TA; Miller HS; Das AF; Saade GR; Nielsen P; Baker J; Yuzko OM; Reznichenko GI; Reznichenko NY; Pekarev O; Tatarova N; Gudeman J; Birch R; Jozwiakowski MJ; Duncan M; Williams L; Krop J
    Am J Perinatol; 2020 Jan; 37(2):127-136. PubMed ID: 31652479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth.
    Edwards AM; Lowry SA; Mikovich S; Forinash AB; Babbar S
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100166. PubMed ID: 33345885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone therapy for prevention of recurrent spontaneous preterm birth in a minority patient population: a retrospective study.
    Mazza GR; Komatsu E; Ponzio M; Bai C; Cortessis VK; Sasso EB
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):252. PubMed ID: 38589796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
    Dodd JM; Grivell RM; OBrien CM; Dowswell T; Deussen AR
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31745984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.